Atle Fund Management Ab
Institutional manager — quarterly 13F holdings, Q ending 2026-03-31
Reported value
$309.7M
Q ending 2026-03-31
Prior quarter
$313.4M
Q ending 2025-12-31
Change
-1.2% QoQ · +36.7% YoY
Positions
39
reported holdings
Largest positions
All 39 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
| Holding | Ticker | Type | Value ▼ | Shares |
|---|---|---|---|---|
| Eli Lilly & Co | LLY | Shares | $26.8M | 40K |
| Merck & Co. Inc | MRK | Shares | $22.9M | 34K |
| Thermo Fisher Scientific Corp | TMO | Shares | $14.4M | 23K |
| Beone Medicines Ltd-Adr | ONC | Shares | $12.1M | 42K |
| Johnson & Johnson | JNJ | Shares | $11.9M | 92K |
| Bridgebio Pharma Inc | BBIO | Shares | $11.9M | 111K |
| Vertex Pharmaceuticals Inc | VRTX | Shares | $11.2M | 23K |
| Abbvie Inc | ABBV | Shares | $10.4M | 108K |
| Stryker Corporation | SYK | Shares | $9.6M | 27K |
| Intuitive Surgical Inc | ISRG | Shares | $9.4M | 71K |
| Ionis Pharmaceuticals Inc | IONS | Shares | $9.4M | 28K |
| Mirum Pharmaceuticals Inc | MIRM | Shares | $9.4M | 196K |
| Cvs Health Corp | CVS | Shares | $9.3M | 24K |
| Revolution Medicines Inc | RVMD | Shares | $9.1M | 617K |
| Boston Scientific Corp | BSX | Shares | $8.8M | 40K |
| Amgen Inc | AMGN | Shares | $8.7M | 22K |
| Edwards Lifesciences Corp | EW | Shares | $8.3M | 107K |
| Alkermes Plc | Shares | $8.2M | 242K | |
| Incyte Corp | INCY | Shares | $8.0M | 51K |
| Neurocrine Biosciences Inc | NBIX | Shares | $7.9M | 90K |
| Gilead Sciences Inc | GILD | Shares | $7.2M | 48K |
| Krystal Biotech, Inc | KRYS | Shares | $6.8M | 38K |
| Cencora Inc | COR | Shares | $6.6M | 23K |
| Irhythm Technologies Inc | IRTC | Shares | $6.3M | 22K |
| Insmed Inc | INSM | Shares | $6.0M | 97K |
| Newamsterdam Pharma Co Nv | Shares | $5.5M | 95K | |
| Celcuity Inc | CELC | Shares | $5.1M | 141K |
| Abivax Sa | ABVX | Shares | $4.8M | 32K |
| Cardinal Health Inc | CAH | Shares | $4.8M | 109K |
| Ideaya Biosciences Inc | IDYA | Shares | $4.0M | 31K |
| Tango Therapeutics Inc | TNGX | Shares | $3.6M | 30K |
| Spyre Therapeutics Inc | SYRE | Shares | $3.5M | 63K |
| Disc Medicine Inc | IRON | Shares | $3.2M | 107K |
| Compass Therapeutics Inc | CMPX | Shares | $3.1M | 42K |
| Universal Health Services Inc | UNH | Shares | $2.8M | 15K |
| Dexcom Inc | DXCM | Shares | $2.6M | 584K |
| Bicara Therapeutics Inc | BCAX | Shares | $2.3M | 1.2M |
| Soleno Therapeutics Inc | SLNOEUR | Shares | $2.2M | 90K |
| Pyxis Oncology Inc | PYXS | Shares | $1.6M | 197K |
Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.